Cellebrite Di Ltd Stock Price, News & Analysis

Cellebrite (NASDAQ: CLBT) has expanded its partnership with the National Center for Missing and Exploited Children (NCMEC) by integrating NCMEC's CyberTipline hash value list into its Cellebrite Inseyets digital forensics software. This integration allows law enforcement agencies to instantly match known child sexual abuse material (CSAM) files, significantly accelerating investigation times.

The integration includes approximately 10-million confirmed CSAM files and will be generally available by June 30, 2025. This development is part of Cellebrite's "Operation Find Them All" (OFTA) initiative, which has already helped rescue hundreds of victims and led to dozens of arrests since its launch in January 2024.

Cellebrite (NASDAQ: CLBT) has announced its acquisition of Corellium, a leader in Arm-based virtualization software, for an enterprise value of $170 million in cash plus $20 million in equity at closing. The deal includes potential additional payments of up to $30 million based on performance milestones. The acquisition combines Cellebrite's digital investigation solutions with Corellium's virtualization technology, enhancing capabilities in vulnerability research, malware analysis, and security testing for Arm-based devices. Corellium's founder Chris Wade will join Cellebrite as CTO. The merger aims to strengthen Cellebrite's offerings in both public and private sectors, particularly in digital investigations, defense, intelligence, and DevSecOps for mobile applications. The transaction is expected to close in summer 2025, pending CFIUS approval and other conditions. Additionally, Cellebrite plans to announce a permanent CEO by mid-August 2025.

Cellebrite (NASDAQ: CLBT), a leader in Digital Investigative solutions, has announced its participation in five major investor conferences during May and June 2025. The company's executives, including CFO Dana Gerner and VP of Investor Relations Andrew Kramer, will attend:

- Craig-Hallum Institutional Investor Conference (May 28) - 1x1 meetings
- TD Cowen Technology Conference (May 29) - Fireside chat at 11:25 AM ET
- Bank of America Technology Conference (June 3) - Fireside chat at 10:50 AM ET
- William Blair Growth Stock Conference (June 4) - Presentation at 4:40 PM CT
- D.A. Davidson Consumer & Technology Conference (June 10) - 1x1 meetings

Webcasts for the fireside chats and presentation will be available on Cellebrite's investor relations website.

Cellebrite (NASDAQ: CLBT) reported strong Q1 2025 financial results with revenue reaching $107.5 million, up 20% year-over-year. The company's subscription revenue grew 21% to $95.8 million, while Annual Recurring Revenue (ARR) increased 23% to $408.0 million. The company achieved a GAAP net income of $17.4 million and Adjusted EBITDA of $23.7 million with a 22% margin. For Q2 2025, Cellebrite expects revenue between $110-116 million and ARR of $416-426 million. The company maintained its full-year 2025 ARR and EBITDA targets while adjusting revenue targets due to U.S. Federal spending environment and timing of new business.

Cellebrite (NASDAQ: CLBT) has announced its Spring 2025 Release, introducing significant enhancements to its Digital Investigation Platform. The release features the new Cellebrite Cloud, powered by AWS, which aims to streamline digital investigations and improve operational efficiency. Key innovations include:

• Advanced media analysis in Inseyets forensics software
• Enhanced Guardian evidence management with AI-powered search
• Improved Smart Search with new dashboard features
• Automated transcription in Pathfinder analytics
• Cloud-based mobile decoding in Endpoint Inspector

The platform addresses the growing challenge of digital evidence review, which currently averages 69 hours per case. Cellebrite's technology serves over 7,000 customers worldwide, supporting approximately 1.5M investigations annually across various sectors including law enforcement, intelligence, and enterprise.

Cellebrite (NASDAQ: CLBT), a global leader in Digital Investigative solutions, has scheduled its first-quarter 2025 financial results announcement for May 14, 2025, before market open. The company will host a conference call and webcast at 8:30 a.m. ET to discuss Q1 2025 results and provide insights on their full-year 2025 outlook.

The earnings call will be accessible via phone (203-518-9783 / 800-267-6316) with Conference ID: CLBTQ125, and through a live webcast. Financial tables and supplemental data will be made available on the company's investor relations website.

Cellebrite (NASDAQ: CLBT) hosted its first-ever Digital Justice Awards ceremony at The National Law Enforcement Museum in Washington, DC, presenting 'Justies' to ten winners across various categories in digital investigations. The awards ceremony preceded the company's sold-out Global C2C (Case-to-Closure) User Summit, which attracted over 700 attendees.

The awards recognized excellence in digital forensics and investigations, with winners including Amy Laabs for Rising Star Award, Heather Charpentier for Mentor of the Year, and David 'Britt' Dove for Case of the Year with the Murdaugh murders investigation. Other categories included Voice for the Voiceless, Design Partner of the Year, Digital Bridge Builder, Community Guardian Award, and Excellence in Digital Forensics.

Cellebrite (Nasdaq: CLBT), a leader in Digital Investigative solutions, has announced the filing of its 2024 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission (SEC). The report, covering the fiscal year ended December 31, 2024, is now accessible through multiple channels.

Shareholders can access the annual report through the company's investor relations website and the SEC's official website. Additionally, stakeholders can request a complimentary hard copy by contacting the company directly at investors@cellebrite.com.

Cellebrite (NASDAQ: CLBT) reported strong Q4 2024 results with revenue of $109.0 million, up 17% year-over-year, driven by 21% growth in subscription revenue. The company achieved Annual Recurring Revenue (ARR) of $395.9 million, up 25% year-over-year, with a recurring revenue dollar-based net retention rate of 124%.

Q4 2024 highlights include GAAP net income of $19.3 million, non-GAAP net income of $26.1 million, and adjusted EBITDA of $28.8 million with a 26.4% margin. For full-year 2024, revenue reached $401.2 million, up 23% year-over-year, with subscription revenue of $353.0 million, up 26%.

The company provided 2025 guidance projecting ARR between $480-495 million (21-25% growth) and revenue of $480-490 million (20-22% growth). Cellebrite achieved a 'Rule of 50' performance in 2024 with 25% ARR growth and 25% adjusted EBITDA margin.